Clinical Significance of Preoperative Neutrophil Lymphocyte Ratio versus Platelet Lymphocyte Ratio in Patients with Small Cell Carcinoma of the Esophagus

Table 3

Univariate and multivariate analyses of OS in SCCE patients.

	Survival (%)	Chi-square	P value	HR (95% CI)	P value
Age (years)		0.686	0.408
≤60	16.7
>60	21.1
Gender		1.841	0.175
Female	38.5
Male	10.0
Tumor length (cm)		6.846	0.009		0.627
≤3	33.3			1.000
>3	8.0			1.229 (0.535–2.821)
Tumor location		0.024	0.877
Upper/middle	20.0
Lower	16.7
Vessel involvement		1.068	0.301
Negative	21.2
Positive	10.0
Depth of invasion		7.433	0.006		0.103
T1-2	33.3			1.000
T3-4a	8.0			2.032 (0.867–4.766)
Nodal metastasis		9.687	0.002		0.092
Negative	40.0			1.000
Positive	7.1			2.182 (0.880–5.411)
Chemoradiotherapy		5.577	0.018		0.011
No	5.9			1.000
Yes	26.9			0.380 (0.180–0.803)
NLR		1.967	0.161
<3.5	22.2
≥3.5	12.5
PLR		7.374	0.007		0.041
<150	25.0			1.000
≥150	6.7			2.272 (1.035–4.984)